Case Based Peer Perspectives

Urology Times presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing urology-based patient cases that highlight the use of novel agents in clinical practice.


A 67-Year-Old-Man with Metastatic Prostate Cancer

January 18th 2023

Stephen J. Freedland, MD, presents the case of a 67-year-old man with metastatic castration-resistant prostate cancer (mCRPC) and discusses the available treatment options and data that influence treatment selection for patients with the disease.

A 60-Year-Old Woman With Muscle-Invasive Bladder Cancer and a 77-Year-Old Man With Muscle-Invasive Bladder Cancer

December 23rd 2022

Karim Chamie, MD, presents 2 cases of patients with muscle-invasive bladder cancer (MIBC), reviews the chosen treatment regimens, and details which clinical and non-clinical factors influence treatment recommendations.

A 65-Year-Old Man with Prostate Cancer and a 77-Year-Old Man with Prostate Cancer

December 21st 2022

Dr Brian Helfand presents two cases of men with prostate cancer and discusses the role of positron emission tomography (PET)-based imaging in management of patients with the disease.

A 74-Year-Old-Man with Metastatic Prostate Cancer

December 16th 2022

Neal Shore, MD, FACS, presents the case of a 74-year-old man with metastatic castration-resistant prostate cancer (mCRPC) and discusses the factors that influence treatment selection for patients with the disease.

A 66-Year-Old-Man with Metastatic Prostate Cancer

August 9th 2022

Jason Hafron, MD, presents the profile of a 66-year-old man with metastatic castration-sensitive prostate cancer, details the available treatment regimens, and discusses clinical trial data on the use of androgen deprivation therapy combined with a treatment-intensifying agent.

A 60-Year-Old Man with Prostate Cancer

July 19th 2022

Gordon A. Brown, DO, presents the case of a man with prostate cancer, reviews available treatment options, and discusses data on combination androgen deprivation therapy/apalutamide in patients with metastatic castration-sensitive prostate cancer.

A 64-Year-Old-Man with Metastatic Prostate Cancer

May 23rd 2022

Neal Shore, MD, presents the case of a 64-year-old man with metastatic prostate cancer, reviews the potential treatment options, including PARP inhibitors, and highlights the importance of genetic testing when selecting treatment regimens.

A 64-Year-Old Man with Elevated PSA Levels

April 21st 2022

Judd W. Moul, MD, FACS, provides insight on screening and diagnosis of prostate cancer, and comments on the use of biomarker tests to aid in risk stratification, management, and treatment.

A 75-Year-Old Woman with High-Risk Muscle Invasive Bladder Cancer

February 7th 2022

Karim Chamie, MD, reviews a high-risk muscle invasive bladder cancer case and highlights potential treatment options.